Evidence map›Paper›PMID 37369720›Full record

ArticleMolecular psychiatry2023

Differential associations of adolescent versus young adult cannabis initiation with longitudinal brain change and behavior.

Matthew D Albaugh, Max M Owens, Anthony Juliano, Jonatan Ottino-Gonzalez, Renata Cupertino, Zhipeng Cao, Scott Mackey, Claude Lepage, Pierre Rioux, Alan Evans and 25 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. The role of subcortical brain tissue iron as an indicator of dopamine neurophysiology in adolescent cannabis use.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cells and Molecules Underpinning Cannabis-Related Variations in Cortical Thickness during Adolescence.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  7. Article
  8. Article
  9. Exploring causal mechanisms of psychosis risk.Neuroscience and biobehavioral reviews · 2024
    Review
  10. The Developmental Trajectory to Cannabis Use Disorder.The American journal of psychiatry · 2024
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 15 institutions in 7 countries.

Matthew D AlbaughDepartment of Psychiatry, University of Vermont, Burlington, VT, USA. malbaugh@uvm.edu.ORCID 0000-0002-5971-6658
Max M OwensDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.ORCID 0000-0002-5560-4077
Anthony JulianoDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Jonatan Ottino-GonzalezDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Renata CupertinoDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.ORCID 0000-0002-3452-0632
Zhipeng CaoDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Scott MackeyDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.ORCID 0000-0001-7817-7437
Claude LepageMcConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada.
Pierre RiouxMcConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada.
Alan EvansMcConnell Brain Imaging Centre, McGill University, Montreal, QC, Canada.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.ORCID 0000-0003-4595-1144
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-0114-4914
Patricia ConrodDepartment of Psychiatry, University of Montreal, Montreal, QC, Canada.ORCID 0000-0002-5570-481X
Sylvane DesrivièresCentre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology & Neuroscience, SGDP Centre, King's College London, London, UK.ORCID 0000-0002-9120-7060
Herta FlorInstitute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.ORCID 0000-0003-4809-5398
Antoine GrigisNeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.
Penny GowlandSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom.ORCID 0000-0002-4900-4817
Andreas HeinzDepartment of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0001-5405-9065
Bernd IttermannPhysikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Berlin, Germany.
Jean-Luc MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM U A10 "Trajectoires développementales en psychiatrie", Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.ORCID 0000-0002-0136-0388
Marie-Laure Paillère MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM U A10 "Trajectoires développementales en psychiatrie"; Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli; and AP-HP.Sorbonne Université, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France.ORCID 0000-0002-0452-2450
Eric ArtigesInstitut National de la Santé et de la Recherche Médicale, INSERM U1299 "Developmental trajectories & psychiatry""; Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli; Gif-sur-Yvette; and Etablissement Public de Santé (EPS) Barthélemy Durand, 91700, Sainte-Geneviève-des-Bois, France.ORCID 0000-0003-4461-7646
Frauke NeesDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.ORCID 0000-0002-7796-8234
Dimitri Papadopoulos OrfanosNeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.ORCID 0000-0002-1242-8990
Tomáš PausDepartments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hospitaliere Universitaire Sainte-Justine, University of Montreal, Montreal, QC, H3T 1C5, Canada.ORCID 0000-0003-1495-9338
Luise PoustkaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, von-Siebold-Str. 5, 37075, Göttingen, Germany.
Sabina MillenetDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159, Mannheim, Germany.
Juliane H FröhnerDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0002-8493-6396
Michael N SmolkaDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0001-5398-5569
Henrik WalterDepartment of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0002-9403-6121
Robert WhelanSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0002-2790-7281
Gunter SchumannCentre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology & Neuroscience, SGDP Centre, King's College London, London, UK.ORCID 0000-0002-7740-6469
Alexandra PotterDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Hugh GaravanDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
IMAGEN Consortium
University of Vermont · USCentre National de la Recherche Scientifique · FRHeidelberg University · DEMcGill Genome Centre · CACommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRHumboldt-Universität zu Berlin · DEKing's College London · GBTechnische Universität Dresden · DETrinity College Dublin · IEPhysikalisch-Technische Bundesanstalt · DEUniversité de Montréal · CAUniversity of Göttingen · DEUniversity of Mannheim · DEUniversity of Nottingham · GBUniversity of Toronto · CA

Funding

Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers R01DA049238 · NIDA · GEORGIA STATE UNIVERSITY · PI CALHOUN, VINCE D, LIU, JINGYU · 2019 to 2023
$2.9M
Axon, Testosterone and Mental Health during AdolescenceR01MH085772 · NIMH · BAYCREST CENTRE FOR GERIATRIC CARE · PI PAUS, TOMAS · 2010 to 2014
$1.5M
Development and clinical validation of multimodal risk algorithms for predicting future internalizing psychopathologyK08MH121654 · NIMH · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ALBAUGH, MATTHEW D · 2020 to 2023
$737k
ENIGMA World Aging CenterR56AG058854 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2018
$683k
Medical Research Council MR/R00465X/1Medical Research Council MR/S020306/1NIA NIH HHS R56 AG058854NIBIB NIH HHS U54 EB020403NIDA NIH HHS R01 DA049238NIMH NIH HHS K08 MH121654NIMH NIH HHS R01 MH085772
6 · The paper itself

Abstract

Leveraging ~10 years of prospective longitudinal data on 704 participants, we examined the effects of adolescent versus young adult cannabis initiation on MRI-assessed cortical thickness development and behavior. Data were obtained from the IMAGEN study conducted across eight European sites. We identified IMAGEN participants who reported being cannabis-naïve at baseline and had data available at baseline, 5-year, and 9-year follow-up visits. Cannabis use was assessed with the European School Survey Project on Alcohol and Drugs. T1-weighted MR images were processed through the CIVET pipeline. Cannabis initiation occurring during adolescence (14-19 years) and young adulthood (19-22 years) was associated with differing patterns of longitudinal cortical thickness change. Associations between adolescent cannabis initiation and cortical thickness change were observed primarily in dorso- and ventrolateral portions of the prefrontal cortex. In contrast, cannabis initiation occurring between 19 and 22 years of age was associated with thickness change in temporal and cortical midline areas. Follow-up analysis revealed that longitudinal brain change related to adolescent initiation persisted into young adulthood and partially mediated the association between adolescent cannabis use and past-month cocaine, ecstasy, and cannabis use at age 22. Extent of cannabis initiation during young adulthood (from 19 to 22 years) had an indirect effect on psychotic symptoms at age 22 through thickness change in temporal areas. Results suggest that developmental timing of cannabis exposure may have a marked effect on neuroanatomical correlates of cannabis use as well as associated behavioral sequelae. Critically, this work provides a foundation for neurodevelopmentally informed models of cannabis exposure in humans.

Indexed as

BrainCannabisMagnetic Resonance ImagingAdolescentAdultFemaleHumansLongitudinal StudiesMaleMarijuana AbuseMarijuana SmokingMarijuana UsePrefrontal CortexProspective StudiesYoung Adult

Identifiers

PMID37369720
PMCPMC12574712
OpenAlexW4382344799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.